Metabolic Explorer (FR:METEX) has released an update.
METabolic EXplorer (METEX), a leader in industrial fermentation, has had its subsidiary METEX NØØVISTAGO and parts of its commercial and R&D activities acquired by Avril, following the Paris Commercial Court’s approval. The sale comes after METEX’s shift into judicial recovery, with the Court expected to announce the judicial liquidation decision soon. This acquisition will lead to the delisting of METEX shares from Euronext, which will have no value, precluding any shareholder payments.
For further insights into FR:METEX stock, check out TipRanks’ Stock Analysis page.
